RedHill Biopharma Ltd 20-F for FY2022
RedHill Biopharma Ltd. (RDHL)
20-F
2023-04-28
For: 2022-12-31
View Original
Added on
April 07, 2026
About this 20-F
RedHill Biopharma Ltd filed this 20-F on April 28, 2023, covering the fiscal year ended December 31, 2022 (FY2022).
Headline figures
Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $61.8M
- down 27.9% from $85.76M a year earlier
- Net loss
- $71.67M
- compared with a net loss of $97.74M a year earlier
- Diluted EPS
- -$0.12
- compared with -$0.21 a year earlier